Singapore markets closed
Straits Times Index
3,290.70 +24.75 (+0.76%) Nikkei
38,229.11 +155.13 (+0.41%) Hang Seng
18,963.68 +425.87 (+2.30%) FTSE 100
8,433.76 +52.41 (+0.63%) Bitcoin USD
60,957.46 -1,938.29 (-3.08%) CMC Crypto 200
1,260.86 -97.15 (-7.16%)
Mersana Therapeutics, Inc. (MRSN)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 2.4650 |
| Open | 2.6100 |
| Bid | 2.6400 x 100 |
| Ask | 2.7500 x 200 |
| Day's range | 2.4700 - 2.7300 |
| 52-week range | 0.8010 - 9.6200 |
| Volume | |
| Avg. volume | 2,170,732 |
| Market cap | 331.598M |
| Beta (5Y monthly) | 1.59 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.4800 |
| Earnings date | 06 Aug 2024 - 12 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 6.57 |
Insider MonkeyMersana Therapeutics, Inc. (NASDAQ:MRSN) Q1 2024 Earnings Call Transcript
Mersana Therapeutics, Inc. (NASDAQ:MRSN) Q1 2024 Earnings Call Transcript May 9, 2024 Mersana Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, and welcome to the Mersana Therapeutics First Quarter 2024 Conference Call and Webcast. Currently, all […]
- GuruFocus.com
Mersana Therapeutics Inc (MRSN) Reports Q1 2024 Financial Results: A Detailed Analysis
Insights into Mersana Therapeutics' Performance and Strategic Updates
ZacksMersana Therapeutics, Inc. (MRSN) Reports Q1 Loss, Misses Revenue Estimates
Mersana Therapeutics (MRSN) delivered earnings and revenue surprises of 11.11% and 5.18%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
© 2024 Yahoo. All rights reserved.